Article Versions Notes

Knop W, Serwin NM, Cecerska-Heryć E, Grygorcewicz B, Dołęgowska B, Gomółka A, Wiśniewska M, Ciechanowski K. Elevated Levels of Renalase, the β-NAD(P)H Isomerase, Can Be Used as Risk Factors of Major Adverse Cardiovascular Events and All-Cause Death in Patients with Chronic Kidney Disease. Biomolecules. 2021; 11(10):1514. https://doi.org/10.3390/biom11101514

Knop, Wojciech, Natalia Maria Serwin, Elżbieta Cecerska-Heryć, Bartłomiej Grygorcewicz, Barbara Dołęgowska, Aleksandra Gomółka, Magda Wiśniewska, and Kazimierz Ciechanowski. 2021. "Elevated Levels of Renalase, the β-NAD(P)H Isomerase, Can Be Used as Risk Factors of Major Adverse Cardiovascular Events and All-Cause Death in Patients with Chronic Kidney Disease" Biomolecules 11, no. 10: 1514. https://doi.org/10.3390/biom11101514

Knop, W., Serwin, N. M., Cecerska-Heryć, E., Grygorcewicz, B., Dołęgowska, B., Gomółka, A., Wiśniewska, M., & Ciechanowski, K. (2021). Elevated Levels of Renalase, the β-NAD(P)H Isomerase, Can Be Used as Risk Factors of Major Adverse Cardiovascular Events and All-Cause Death in Patients with Chronic Kidney Disease. Biomolecules, 11(10), 1514. https://doi.org/10.3390/biom11101514